19-13909821-A-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017721.5(CC2D1A):c.61-2A>G variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.0000648 in 1,589,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_017721.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CC2D1A | ENST00000318003.11 | c.61-2A>G | splice_acceptor_variant, intron_variant | Intron 1 of 28 | 1 | NM_017721.5 | ENSP00000313601.6 | |||
CC2D1A | ENST00000589606.5 | c.61-2A>G | splice_acceptor_variant, intron_variant | Intron 1 of 28 | 1 | ENSP00000467526.1 | ||||
CC2D1A | ENST00000585896.5 | n.300-2A>G | splice_acceptor_variant, intron_variant | Intron 1 of 9 | 2 | |||||
CC2D1A | ENST00000680439.1 | n.219-2A>G | splice_acceptor_variant, intron_variant | Intron 1 of 6 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000801 AC: 19AN: 237216Hom.: 0 AF XY: 0.0000699 AC XY: 9AN XY: 128794
GnomAD4 exome AF: 0.0000647 AC: 93AN: 1437792Hom.: 0 Cov.: 31 AF XY: 0.0000618 AC XY: 44AN XY: 711786
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74294
ClinVar
Submissions by phenotype
Intellectual disability, autosomal recessive 3 Pathogenic:2
Variant summary: CC2D1A c.61-2A>G is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. The variant allele was found at a frequency of 8e-05 in 237216 control chromosomes. c.61-2A>G has been reported in the literature in individuals affected with Mental retardation (Hou_2020) in a heterozygous state, and a second pathogenic allele has not been identified. This report does not provide unequivocal conclusions about association of the variant with Intellectual Disability 3. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
Inborn genetic diseases Pathogenic:1
The c.61-2A>G intronic variant results from an A to G substitution two nucleotides upstream from coding exon 2 in the CC2D1A gene. This nucleotide position is highly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to abolish the native splice acceptor site; however, direct evidence is unavailable. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as likely pathogenic. -
not provided Pathogenic:1
This sequence change affects an acceptor splice site in intron 1 of the CC2D1A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CC2D1A are known to be pathogenic (PMID: 16033914). This variant is present in population databases (rs200450636, gnomAD 0.2%). Disruption of this splice site has been observed in individual(s) with intellectual disability (PMID: 31980526). ClinVar contains an entry for this variant (Variation ID: 1751762). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at